PULSE BIOSCIENCES, INC. — Director's Dealing 2020

Jun 19, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Pulse Biosciences, Inc. (PLSE)
CIK: 0001625101
Period of Report: 2020-06-17

Reporting Person: Zanganeh Maky (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-06-17	Common Stock	P	7950	$7.01	Acquired	105574	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	352500	Direct
Common Stock	27000	Indirect
Common Stock	14000	Indirect

Footnotes

F1: The Reporting Person's immediate family member acquired the shares from a banking institution due to an error by such institution in connection with subscriptions for the Issuer's rights offering. Such shares were not acquired from the Issuer.